- Recent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® Test
- Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner
- Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance
- New Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis
- Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference
- Castle Biosciences Expands Evidence Supporting the Performance of its TissueCypher® Barrett’s Esophagus Test in Predicting Future Development of Esophageal Cancer Through Multiple Data Presentations at DDW 2024
- Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for “Best Overall Mental Health Solution”
- Largest Prospective Study to Date Further Supports Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with DecisionDx-UM Class Result
- DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck
More ▼
Key statistics
On Wednesday, Castle Biosciences Inc (CSTL:NMQ) closed at 21.25, -17.99% below its 52-week high of 25.91, set on May 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 21.40 |
---|---|
High | 21.58 |
Low | 20.67 |
Bid | 17.32 |
Offer | 22.21 |
Previous close | 21.26 |
Average volume | 309.72k |
---|---|
Shares outstanding | 27.61m |
Free float | 26.77m |
P/E (TTM) | -- |
Market cap | 586.65m USD |
EPS (TTM) | -1.15 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼